RAPT Therapeutics, Inc. (RAPT) Ownership

$34.47

$2.38 (7.42%)
Last update: 04:00 PM EST
Day's range
$31.72
Day's range
$34.73

RAPT Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
TCG CROSSOVER MANAGEMENT, LLC 11/17/2025 1.64 M $42.20 M   0.00% 6.07%
FORESITE CAPITAL MANAGEMENT VI LLC 11/14/2025 1.56 M $40.30 M   0.00% 5.80%
RTW INVESTMENTS, LP 11/14/2025 1.47 M $37.92 M   0.00% 5.46%
ORBIMED ADVISORS LLC 11/14/2025 1.09 M $28.02 M   -33.82% 4.03%
BOONE CAPITAL MANAGEMENT LLC 11/14/2025 782.46 K $20.18 M   100.00% 2.90%
DEEP TRACK CAPITAL, LP 11/14/2025 751.42 K $19.38 M   0.00% 2.79%
VANGUARD GROUP INC 11/07/2025 696.19 K $17.95 M   -20.89% 2.58%
NANTAHALA CAPITAL MANAGEMENT, LLC 11/14/2025 623.28 K $16.07 M   -34.50% 2.31%
IKARIAN CAPITAL, LLC 11/14/2025 615.00 K $15.86 M   100.00% 2.28%
SIREN, L.L.C. 11/13/2025 580.47 K $14.97 M   100.00% 2.15%
REDMILE GROUP, LLC 11/14/2025 552.59 K $14.25 M   -12.38% 2.05%
SOLEUS CAPITAL MANAGEMENT, L.P. 11/14/2025 537.90 K $13.87 M   100.00% 2.00%
ADAR1 CAPITAL MANAGEMENT, LLC 11/14/2025 507.77 K $13.10 M   -35.17% 1.88%
FCPM III SERVICES B.V. 11/14/2025 344.24 K $8.88 M   -21.80% 1.28%
FMR LLC 11/13/2025 248.38 K $6.41 M   12,729.44% 0.92%
BOOTHBAY FUND MANAGEMENT, LLC 11/14/2025 223.86 K $5.77 M   100.00% 0.83%
PERCEPTIVE ADVISORS LLC 11/14/2025 183.89 K $4.74 M   0.00% 0.68%
IKARIAN CAPITAL, LLC 11/14/2025 175.00 K $4.51 M   100.00% 0.65%
INVESCO LTD. 11/13/2025 140.54 K $3.62 M   100.00% 0.52%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 121.46 K $3.13 M   -13.28% 0.45%
SUMMITTX CAPITAL, L.P. 11/14/2025 91.91 K $2.37 M   100.00% 0.34%
BLACKROCK, INC. 11/12/2025 89.50 K $2.31 M   -0.39% 0.33%
EUCLIDEAN CAPITAL LLC 11/14/2025 82.23 K $2.12 M   0.00% 0.31%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 11/14/2025 79.98 K $2.06 M   100.00% 0.30%
BOOTHBAY FUND MANAGEMENT, LLC 11/14/2025 63.70 K $1.64 M   100.00% 0.24%
GOLDMAN SACHS GROUP INC 11/14/2025 61.58 K $1.59 M   176.55% 0.23%
AMERIPRISE FINANCIAL INC 11/14/2025 51.41 K $1.33 M   100.00% 0.19%
BALYASNY ASSET MANAGEMENT L.P. 11/14/2025 50.35 K $1.30 M   100.00% 0.19%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 45.38 K $1.17 M   100.00% 0.17%
MILLENNIUM MANAGEMENT LLC 11/14/2025 39.28 K $1.01 M   75.16% 0.15%
STATE STREET CORP 11/14/2025 37.38 K $964.11 K   96.11% 0.14%
TWO SIGMA INVESTMENTS, LP 11/14/2025 34.82 K $897.96 K   -20.18% 0.13%
SUPERSTRING CAPITAL MANAGEMENT LP 11/14/2025 34.45 K $888.44 K   32.32% 0.13%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 34.31 K $884.88 K   -45.08% 0.13%
UBS GROUP AG 11/13/2025 28.81 K $742.96 K   680.28% 0.11%
MORGAN STANLEY 11/14/2025 22.10 K $569.86 K   22.66% 0.08%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2025 20.63 K $531.92 K   32.00% 0.08%
NORTHERN TRUST CORP 11/14/2025 17.02 K $438.95 K   -31.20% 0.06%
MARSHALL WACE, LLP 11/13/2025 16.85 K $434.43 K   100.00% 0.06%
ACADIAN ASSET MANAGEMENT LLC 11/13/2025 16.79 K $432.00 K   -81.57% 0.06%
CITADEL ADVISORS LLC 11/14/2025 15.53 K $400.52 K   100.00% 0.06%
ROYAL BANK OF CANADA 11/14/2025 14.45 K $373.00 K   0.11% 0.05%
HIGHTOWER ADVISORS, LLC 11/07/2025 12.63 K $325.60 K   100.00% 0.05%
POINT72 ASSET MANAGEMENT, L.P. 11/14/2025 12.38 K $319.24 K   100.00% 0.05%
GSA CAPITAL PARTNERS LLP 11/07/2025 10.56 K $272.00 K   -13.06% 0.04%
CITADEL ADVISORS LLC 11/14/2025 10.42 K $268.84 K   100.00% 0.04%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 10.00 K $257.90 K   0.00% 0.04%
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 11/14/2025 9.17 K $236.55 K   100.00% 0.03%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 8.93 K $230.65 K   100.00% 0.03%
CITADEL ADVISORS LLC 11/14/2025 8.30 K $214.06 K   -42.49% 0.03%

RAPT Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 88 institutional investors and hedge funds held shares of RAPT Therapeutics, Inc.. The most heavily invested institutionals were:

TCG Crossover Management, LLC: 1.64 M

Foresite Capital Management VI LLC: 1.56 M

RTW INVESTMENTS, LP: 1.47 M

ORBIMED ADVISORS LLC: 1.09 M

BOONE CAPITAL MANAGEMENT LLC: 782,461

Deep Track Capital, LP: 751,422

50.55% of RAPT Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 24.60 M shares in the last 24 months. This purchase volume represents approximately $848.00 M in transactions.